Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adel Shahnam

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Australasian Journal of Dermatology|September 8, 2015
Sun-protection practices among undergraduates at an Australian UniversityAdel Shahnam, Indira Samarawickrema, Sayed Ali
Annual Review of Medicine|November 21, 2024
Circulating Tumor DNA: A Pan-Cancer Biomarker in Solid Tumors with Prognostic and Predictive ValueNadia Hitchen, Adel Shahnam, Jeanne Tie
Asia-Pacific Journal of Clinical Oncology|February 20, 2021
Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosisUdit Nindra, Adel Shahnam, Kate L Mahon
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 6, 2019
Prognostic Utility of CDX2 and PD-L1 in Rectal CancerAdel Shahnam, Elizabeth Paver, Bella Nguyen, et al.
Clinical Case Reports|July 9, 2024
A case for the use of chemotherapy in hereditary mitochondrial optic neuropathies: Successful administration of cisplatin/etoposide in a male patient with testicular seminoma and Leber's hereditary optic neuropathyJean-Luc Vrisakis, Clare L Fraser, Adel Shahnam, et al.
Pharmacogenomics|September 17, 2016
Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysisAdel Shahnam, Zainab Ridha, Michael D Wiese, et al.
Current Oncology (Toronto, Ont.)|June 23, 2022
Growing Teratoma Syndrome in the Setting of Sarcoidosis: A Case Report and Literature ReviewAdel Shahnam, Robyn Sayer, Unine Herbst, et al.
Cancer Biology & Medicine|September 14, 2019
Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial dataAshley M Hopkins, Adel Shahnam, Sasha Zhang, et al.
Translational Lung Cancer Research|April 11, 2022
The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapySarah Badaoui, Adel Shahnam, Ross A McKinnon, et al.
Gastrointestinal Tumors|October 30, 2023
Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric CancersAdel Shahnam, Udit Nindra, Nicholas McNamee, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Australasian Journal of Dermatology|September 8, 2015
Sun-protection practices among undergraduates at an Australian UniversityAdel Shahnam, Indira Samarawickrema, Sayed Ali
Annual Review of Medicine|November 21, 2024
Circulating Tumor DNA: A Pan-Cancer Biomarker in Solid Tumors with Prognostic and Predictive ValueNadia Hitchen, Adel Shahnam, Jeanne Tie
Asia-Pacific Journal of Clinical Oncology|February 20, 2021
Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosisUdit Nindra, Adel Shahnam, Kate L Mahon
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 6, 2019
Prognostic Utility of CDX2 and PD-L1 in Rectal CancerAdel Shahnam, Elizabeth Paver, Bella Nguyen, et al.
Clinical Case Reports|July 9, 2024
A case for the use of chemotherapy in hereditary mitochondrial optic neuropathies: Successful administration of cisplatin/etoposide in a male patient with testicular seminoma and Leber's hereditary optic neuropathyJean-Luc Vrisakis, Clare L Fraser, Adel Shahnam, et al.
Pharmacogenomics|September 17, 2016
Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysisAdel Shahnam, Zainab Ridha, Michael D Wiese, et al.
Current Oncology (Toronto, Ont.)|June 23, 2022
Growing Teratoma Syndrome in the Setting of Sarcoidosis: A Case Report and Literature ReviewAdel Shahnam, Robyn Sayer, Unine Herbst, et al.
Cancer Biology & Medicine|September 14, 2019
Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial dataAshley M Hopkins, Adel Shahnam, Sasha Zhang, et al.
Translational Lung Cancer Research|April 11, 2022
The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapySarah Badaoui, Adel Shahnam, Ross A McKinnon, et al.
Gastrointestinal Tumors|October 30, 2023
Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric CancersAdel Shahnam, Udit Nindra, Nicholas McNamee, et al.
Pageof 3